Environmentally friendly water cremation service to open in Christchurch
Photo:
Supplied/Deborah Richards
New Zealand's first water crematorium is opening in Christchurch on Friday, giving people a new option for
what happens to their body
after they die.
Water cremation, also called alkaline hydrolysis or resomation, was used in several countries as an
environmentally friendly alternative to traditional cremation
.
It involves a body being put into a tube containing 95 percent water and five percent alkaline, and heated up and pressurised for about four hours.
The remains are then given back to the relatives, while the water is treated and put back into the water cycle.
Christchurch Water Crematorium director Debbie Richards said it had been a long battle to get the process approved in New Zealand.
"After working on this for more than seven years, we are thrilled to be able to offer water cremation as a far more environmentally sustainable end-of-life choice," she said.
The project is a partnership between Water Cremation Aotearoa and funeral service provider Bell, Lamb and Trotter.
Richards said the water cremation process produced no carbon emissions.
"Anything not of the body - such as pacemakers and implants remain behind, clean and intact, and can be recycled. The bones that remain after the process is complete can be returned to the family as bones or white ash, it is their choice," she said.
A single traditional flame cremation produced about 180 to 240kg of carbon emissions, Richards said.
"I think that those people that want to tread more lightly and leave less of a footprint environmentally, and are concerned about carbon emission and want to do something about climate change, they will find this appealing," she said.
"A lot of people perceive it as gentler than flame cremation as well so for those reasons I think people will definitely choose it."
Richards said the water cremation service was being offered for $1350.
"We're offering it just through Bell, Lamb and Trotter at the moment. It works out as a little bit cheaper than a flame cremation and one of the reasons for that is that there's no casket required. We can't put a casket inside a resomater, we can only put things that are protein based," she said.
"We wrap a body in some beautiful New Zealand wool, we've got that from Wisewool up in Gisborne where they have the sheep and they make the beautiful blanketing that we wrap people in as a shroud."
Bell, Lamb and Trotter managing director Andrew Bell said this new technology was a significant development for the funeral industry.
"Bell, Lamb and Trotter was the first company in the country to introduce embalming in 1896 and then flame cremation became available in 1909 which is probably the last time something so noteworthy has happened in the funeral services sector," he said.
Bell said with about 80 percent of the company's clients choosing cremation over burial, he believed water cremation would have wide appeal.
Christchurch Mayor Phil Mauger will formally open the water crematorium at Bell, Lamb and Trotter's St Asaph Street site on Friday.
Sign up for Ngā Pitopito Kōrero
,
a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
29 minutes ago
- RNZ News
Billboard camera footage used by transport agency to spot cars and trucks
NZTA Waka Kotahi has used privately-owned automated number plate recognition cameras to identity number plates. File photo. Photo: 123RF Footage from cameras in billboards at city intersections have been secretly used by the NZ Transport Agency for the first time to spot cars and trucks. NZTA Waka Kotahi's trial started in February, and is designed to combat fraud by illegal garages issuing warrants of fitness to cars, or passing trucks. Two sources close to the vehicle inspection industry say the move is surprising and questioned why the agency would do it, especially with using third-party technology systems. Police already tap into privately-owned automated number plate recognition (ANPR) cameras to identity number plates hundreds of times a day. But this is the first known use of that power by another state agency. "The ANPR donor cameras in the trial are not being used 'to spy on mechanics issuing warrants', nor would they be capable of being used for that purpose," NZTA told RNZ. "These cameras are typically located in billboards at urban intersections. "The trial is simply looking at the potential for using images gathered by these cameras to be used as proof of the location of a particular vehicle at a point in time." An inspector who claimed they had checked a car in Auckland at a certain time could be exposed if the car was spotted at a Christchurch intersection at that time, it said. It "could be of benefit in supporting investigations into specific cases where fraudulent or illegal activity is suspected". A well-connected industry source told RNZ: "Yeah, that has been a bit secret." NZTA might not have wanted to tip people off, the source said. "For the purpose the agency is stating, I don't have much issue with that, but the way they have gone about it is what alarms me. Especially because it's third-party [cameras and ANPR system]. "What else might they use them for?" NZTA Waka Kotahi said it was not using the images in any actual fraud investigations, but only as a test for potential future use. The test is separate from how the agency is taking over many speed and red-light-runner cameras from police, and replacing some with higher-tech models, which it will own. A second source active in the industry was appalled by the move. "Oh my god," they said. "It is part of your right to know the audit process you go through. You can't sabotage your process because of a trial." Months of inquiries by RNZ in 2018 showed up mass deficiencies in NZTA's oversight of how truck certificates of fitness were being issued. The systems were reviewed and changed. There have been further reports of inspectors anonymously recounting examples of how they feel they have been subject to unfair targeting by the agency. "You have got layers and layers of issues here," said the second source. "What's the limit [of surveillance]?" They questioned why was the camera sting even needed when fraud would "show up in paperwork. There will be tons of other evidence that can be used against people". Many supermarkets, petrol stations, other businesses and councils have a total of thousands of cameras that link into ANPR software systems run by two Auckland companies - Auror and SaferCities. The new trial uses SaferCities vGrid system , NZTA said. Its system covered electronic billboard operators such as LUMO, which had built-in cameras with ANPR software, and CCTV operators including councils, individual businesses and car park operators, the agency said. Police accessed the vGrid system more than 400,000 times last year. "NZTA only has access to still images from ANPR donor cameras whose owners have specifically agreed to our usage," Waka Kotahi told RNZ in the OIA response. "Currently, this only includes LUMO and more recently, Hamilton City Council." RNZ approached LUMO for comment. As of 2022, the country had at least 1400 digital billboards and screen-posters, many of them with smart technology and ANPR cameras . The police tapped the ANPR systems 700,000 times last year. In October, two district court judges dismissed legal challenges to the police using them so much without a warrant, though it is expected there will be at least one appeal against that finding. The fraud camera trial comes at the same time Waka Kotahi is reviewing the WOF-COF system to reduce how often collectors of old vehicles, and motorhome users, have to get a warrant. The agency has been increasing a lot of the fees it charges motorists since 2023. Another batch of rises is due next January that are expected to push up total fees collected by $10m to $264m . Camera footage could be used where it was suspected that WoFs or CoFs had been issued to vehicles which had not been inspected at the time or place recorded by a vehicle inspector, the transport agency said. It gave a hypothetical scenario to RNZ: "If NZTA was investigating a vehicle inspector suspected of fraud, and if the inspector had issued a WoF to a vehicle which was recorded as having been inspected at a WoF garage in Auckland at 2pm on 1 July, 2025, and we were able to access a still image from a donor camera of the same vehicle driving past a billboard located in Christchurch at 3:30pm on 1 July, 2025, this could potentially be used as evidence to prove that the WoF had been issued fraudulently, because the vehicle was not in Auckland at the time of the recorded inspection." This would not be a part of regular compliance monitoring, it said. Regular compliance monitoring included scheduled reviews where compliance officers visited inspection sites, as well as 'mystery shopper' activity. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
RNZ News
an hour ago
- RNZ News
'Awful error': Two-month-old dies following overdose after pharmacy allegedly gives medication at wrong dosage
By Sam Sherwood, Bellamere Duncan died at Starship Hospital on 19 July. Photo: Supplied Warning: This story has details of the death of an infant A two-month-old baby died following an overdose after she was allegedly given medication at an adult dosage by a pharmacy, RNZ can reveal. In an exclusive interview, her grieving parents are calling for a law change that would make it mandatory for medication to be checked by two people before it is dispensed. The revelations have prompted the Ministry of Health and Health New Zealand to "urgently" undertake a joint review into the incident, with Medsafe visiting the pharmacy to ensure they are safe to continue operating. The Pharmacy Council, which is also investigating, says it is "clear that an awful error has occurred". Bellamere Arwyn Duncan was born at 31 weeks and five days at Palmerston North Hospital on 2 May. Her parents Tempest Puklowski and Tristan Duncan knew from the scans she was going to be "quite tiny", and were told she would be early but no one expected she would come as early as she did. "That was definitely on her own accord," Puklowski, a first-time mum, says. "She sort of just made up her mind, and was like 'I'm coming out'." Bellamere, who weighed 1023 grams when she was born, spent about two months in the neonatal unit. Puklowski says she could not wait to bring her baby home and was excited when she was discharged on 24 June. Do you know more? Email While in hospital, Puklowski gave Bellamere her drops for Vitamin D. Nurses also administered her phosphate. When they left hospital they were given some Vitamin D in a little bottle, and a prescription for iron and Vitamin D. The following day Duncan went to a Manawatu pharmacy with the prescriptions. He was given the iron, but says the pharmacy refused to give the Vitamin D as the staff thought the dosage was "too high for her age and her weight". The staff said they would call the neonatal unit and follow-up. A few days later Puklowski received a call from the unit to organise a home care visit. During the call she was asked if she had any concerns, and Puklowski asked if they had been contacted about the Vitamin D. They had not, and said they would follow up and rewrite the prescription along with a prescription for phosphate. The homecare visit went well. Bellamere had put on weight, and was "doing well", Puklowski recalls. "She was settling in perfect." Bellamere Duncan's parents were allegedly given an adult dosage of phosphate by the pharmacy. Photo: Supplied A day after the phone call, on 2 July, Duncan went to the pharmacy to collect the medication and came home with just the phosphate. Unbeknown to the parents, they had allegedly been given an adult dosage of phosphate. The label on the medication directed them to dissolve one 500mg tablet of phosphate twice daily in a glass of water. Puklowski said given the pharmacy's refusal to give them the Vitamin D, they did not even think to question the dosage. That evening they gave Bellamere her first dose of the medicine in her formula water. They would give her three bottles in 24 hours as was recommended. The couple noticed in that period that her eating was off, and thought she was "extra gassy", Puklowski says. "She was still feeding fine. She just wasn't maybe going through a whole bottle compared to what she was," she recalls. Then, the day after she got her first dosage, Bellamere suddenly stopped breathing. "We were like oh shit, I went straight into panic," Puklowski says. "Tristan had to start administering CPR, and I was on the phone to the ambulance which arrived very quickly, within at least five to 10 minutes." Bellamere was flown to Starship Hospital after she suddenly stopped breathing. Photo: RNZ / Cole Eastham-Farrelly Bellamere was taken to hospital and rushed to the emergency department. Once she was stabilised she was taken to the neonatal unit where she stayed overnight before she was flown to Starship Hospital. "We were definitely terrified and more confused than anything about what was going on," Puklowski says. The couple told the doctors they were worried they had overfed her, and her body was struggling to get it out. "I was trying to think of what had changed in the past 24 hours, which was her phosphate," Puklowski says. The couple had taken a bottle of the medicine with them to Starship Hospital. She gave it to the staff who saw that they had been given an adult dose. The staff then requested the original prescription which confirmed the script had been written with the correct dosage, but somehow the pharmacy had given the wrong dosage, Puklowski says. "I keep thinking about how much she ended up having and it just makes me feel sick." Once at Starship Hospital the couple were told they would "have to make some hard decisions". "But then we went and saw her. She was still moving and her eyes were still opening. "So we were like, 'No. She's our strong little fighter. I mean, look at how well she's done so far'." Tragically, Bellamere died at Starship Hospital on 19 July. "It was completely horrible," Puklowski says of having to say goodbye to her baby. A preliminary coroner's opinion is that Bellamere died of phosphate toxicity, her parents confirmed. A week on from their daughter's death, the couple are still in shock. Puklowski says she is in "disbelief". "They're just numb," Puklowski's mother, Rachelle Puklowski says. "It's completely traumatised them. They just watched Bella pass twice, once in their home and then again up at the hospital." The owner of the Manawatu pharmacy that dispensed the medication said in a statement to RNZ the baby's death was "a tragedy". "Our sympathy is with the family and whānau. This is a very difficult time. "We are looking into what has happened to try to understand how this took place. There will also be external reviews which we will work with." RNZ asked the owner how the medication was given at the wrong dosage, whether they disputed the allegations, when the pharmacy became aware the wrong dosage had been given, and what confidence people could have about other medication received from the pharmacy. The owner said the pharmacy was "devastated about what has happened and are investigating to find out how this occurred". "It is not appropriate to comment further at this stage." Duncan describes what happened to his daughter as "negligence". "How was it overlooked?" Puklowski wants to know. "Not even just in the initial making of it, but in the handing of it to us. They denied us the Vitamin D because they thought the dosage was too high for her age and weight, but can proceed to give us a full adult dosage of phosphate, like it just makes no absolute sense," she said. "They have to make sure they realise the kind of mistake that they have made, and that something has been done about it." The couple are adamant they want changes to the system for giving out medication. "It's the sort of thing that can't really be overlooked. "There needs to be something better in effect, rather than just relying on one person to make sure you're getting the right prescription, having at least a few eyes." Pharmacy Council chief executive Michael Pead said in a statement to RNZ the council's "heartfelt thoughts" were with Bellamere's family following the "absolute tragedy". "It is clear that an awful error has occurred, and as the regulator for pharmacists, we are working on understanding every detail of what happened, what went wrong, how it went wrong, and who was involved. The Pharmacy Council is working promptly to take any immediate steps required to ensure public safety. "Our enquiry and investigation processes are currently underway and, until these are complete, we cannot provide any further details. At the end of the process, we will make any recommended changes to ensure as best as possible an event like this does not happen again." The Pharmacy Council operated within a wider framework of organisations responsible for the protection of public health and safety, Pead said. "We have also referred the incident to other relevant organisations to ensure they can act on any matters that may fall into their remit. "We would emphasise that situations of this nature are extremely rare. No health practitioner goes to work aiming to cause harm, and New Zealanders can have faith that the pharmacists working in their communities and hospitals are vigilant about medicine dosage and patient safety." Pead said the council set the standard that all pharmacists follow a "logical, safe and methodical procedure" to dispense therapeutic products. Every pharmacy would have their own standard operating procedures that covered the dispensing and checking process, he said. "It involves checking the prescription for legality and eligibility, clinical assessment and accuracy check. "The check by a second person (separation of dispenser and checker roles) is considered best practice and is often built into the checking process in a pharmacy's procedures. The pharmacist is responsible for the final check. Sometimes this may not be possible for a sole charge pharmacist, working alone in the dispensary. It is recommended that a second self-check should be carried out, taking a few moments between the prescriptions to 'reset' and performing the final check with care." Health New Zealand and the Ministry of Health released a joint statement to RNZ, extending their "heartfelt condolences" to Bellamere's family. "Health New Zealand and the Ministry of Health take very seriously incidents like these, which while rare, are always thoroughly investigated to identify any lessons that can be learned. "Both agencies involved are acting urgently in undertaking a joint review into this incident, exploring all aspects of the care provided." Health New Zealand is undertaking a serious incident review and the Ministry of Health will be looking at actions taken by health services in the community. "This will occur alongside providing any information requested by the coroner." On Friday, a Ministry of Health spokesperson told RNZ that Medsafe had visited the pharmacy where the medicine was dispensed and completed an initial assessment that the pharmacy was safe to continue operating. "That initial assessment is part of a rapid audit and site visit of the pharmacy which is being carried out by Medsafe, aimed to provide additional assurance that the pharmacy is meeting expected standards." The actions taken by Medsafe and the Pharmacy Council would help inform the ongoing review, the spokesperson said. "These measures are occurring alongside providing any information requested by the coroner." Health Minister Simeon Brown said in a statement to RNZ he was "heartbroken" for Bellamere's family who had "inexplicably lost their baby in tragic circumstances". "My thoughts are with them at this incredibly difficult time. "I am advised that the Pharmacy Council has taken immediate action and is investigating this incident. The council has also advised other appropriate regulators."
RNZ News
9 hours ago
- RNZ News
Medsafe considers crackdown on import of unregulated peptide medications
Medsafe says people are buying unregulated peptides from websites that make health claims for which there is little or no evidence. Photo: Science Photo Li / WBU / Science Photo Library via AFP New Zealanders are buying potentially high-risk, unregulated peptide medications from overseas websites to treat sexual dysfunction, memory loss and more. Medsafe is considering a crackdown, warning many are sold based on unproven claims. It hopes to have several of them - and similar ones that may crop up - classified as prescription medicines, making it illegal to import them without a prescription. In a written submission to the Medicines Classification Committee, Medsafe said peptides were being bought from websites that made claims they could help with "cognitive enhancement, hair growth, libido enhancers, sexual dysfunction, immune enhancers and cancer treatment", and more. However, there was often little, if any, evidence to back up the claims. Most had not been tested for safety and efficacy on humans. Medsafe could not seize peptides at the border, if they were not classed as prescription medicine. Instead, it released the products to the purchasers with a "high-risk medicine letter". "This is posing a risk to health, as the product's quality, efficacy and interactions with other medicines is unknown," the submission said. Because new peptide substances were created all the time, Medsafe asked the committee to class whole groups of them as prescription medicines, so future versions that fell within the group would still be covered. Many websites that sold peptides claimed to sell them "for research purposes", but customers intended to use them therapeutically, the submission said. Fifty-six parcels were intercepted at the border in the year to May, containing peptides or prescription medications known as selective androgen receptor modulators (SARMS). Customs said it couldn't say how many got through without interception. Medsafe said the classification review would take into consideration the safety and appropriateness of being able to import these products, as well the risks of limiting access. The committee considered the submission at a meeting on Wednesday and its decision has not been made public yet. The final decision on medicine classification changes will be made by the Minister of Health at the committee's recommendation. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
